ID: ALA38582

Max Phase: Preclinical

Molecular Formula: C16H20N4O

Molecular Weight: 284.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1C2CCC1CC(NC(=O)c1n[nH]c3ccccc13)C2

Standard InChI:  InChI=1S/C16H20N4O/c1-20-11-6-7-12(20)9-10(8-11)17-16(21)15-13-4-2-3-5-14(13)18-19-15/h2-5,10-12H,6-9H2,1H3,(H,17,21)(H,18,19)

Standard InChI Key:  PCQJPTSZYKYPDE-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin 3 (5-HT3) receptor 617 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serotonin 3 (5-HT3) receptor 1834 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 4 (5-HT4) receptor 653 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 4 (5-HT4) receptor 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 284.36Molecular Weight (Monoisotopic): 284.1637AlogP: 1.92#Rotatable Bonds: 2
Polar Surface Area: 61.02Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.01CX Basic pKa: 9.10CX LogP: 0.96CX LogD: -0.43
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.89Np Likeness Score: -1.15

References

1. Fludzinski P, Evrard DA, Bloomquist WE, Lacefield WB, Pfeifer W, Jones ND, Deeter JB, Cohen ML..  (1987)  Indazoles as indole bioisosteres: synthesis and evaluation of the tropanyl ester and amide of indazole-3-carboxylate as antagonists at the serotonin 5HT3 receptor.,  30  (9): [PMID:3625701] [10.1021/jm00392a001]
2. Bermudez J, Fake CS, Joiner GF, Joiner KA, King FD, Miner WD, Sanger GJ..  (1990)  5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives.,  33  (7): [PMID:2362270] [10.1021/jm00169a016]
3. Schaus JM, Thompson DC, Bloomquist WE, Susemichel AD, Calligaro DO, Cohen ML..  (1998)  Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.,  41  (11): [PMID:9599243] [10.1021/jm970857f]
4. Robertson DW, Bloomquist W, Cohen ML, Reid LR, Schenck K, Wong DT..  (1990)  Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.,  33  (12): [PMID:2258903] [10.1021/jm00174a013]
5. Kaumann A, King F, Young R.  (1992)  Indazole as an indole bioisostere: 5-HT4 receptor antagonism.,  (5): [10.1016/S0960-894X(00)80160-2]

Source